ABERCROMBIE GEORGE B
SEC CIK 1485939 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BCRX | BIOCRYST PHARMACEUTICALS INC | Dir | 36.4K | — | $1.48M | 15 | 2021-07-15 | 2024-06-12 |
Most active insiders at BCRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Barnes Alane P | CLO | — | $3.46M |
| 2 | HEGGIE THERESA | Dir | — | $504.8K |
| 3 | McKee Amy E | Dir | — | $100.3K |
| 4 | SANDERS MACHELLE | Dir | — | $68.5K |
| 5 | Menon Sandeep | Chief R, D Off | — | — |
| 6 | Ghias Babar | CFO | — | — |
| 7 | Gayer Charles K | Pres, CCO | — | — |
| 8 | Milne Jill C. | Dir | — | — |
| 9 | Frank Steven | Dir | — | — |
| 10 | Galson Steven K | Dir | — | — |
ABERCROMBIE GEORGE B made no open-market trades at BCRX in the last 12 months.
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-14 | 2024-06-12 | BCRX | BIOCRYST PHARMACEUTICALS INC | ABERCROMBIE GEORGE B | Dir | A - Grant | $0.00 | +6,820 | 36.4K | +23% | $0 |
| D | 2023-06-15 | 2023-06-13 | BCRX | BIOCRYST PHARMACEUTICALS INC | ABERCROMBIE GEORGE B | Dir | A - Grant | $0.00 | +16.7K | 29.6K | +130% | $0 |
| D | 2022-06-09 | 2022-06-07 | BCRX | BIOCRYST PHARMACEUTICALS INC | ABERCROMBIE GEORGE B | Dir | A - Grant | $0.00 | +12.9K | 12.9K | New | $0 |
| D | 2022-04-20 | 2022-04-18 | BCRX | BIOCRYST PHARMACEUTICALS INC | ABERCROMBIE GEORGE B | Dir | S - Sale+OE | $11.04 | -5,000 | 0 | -100% | -$55.2K |
| D | 2022-04-20 | 2022-04-18 | BCRX | BIOCRYST PHARMACEUTICALS INC | ABERCROMBIE GEORGE B | Dir | M - OptEx | $3.32 | +5,000 | 5,000 | New | +$16.6K |
| D | 2022-02-16 | 2022-02-15 | BCRX | BIOCRYST PHARMACEUTICALS INC | ABERCROMBIE GEORGE B | Dir | M - OptEx | $3.32 | +5,000 | 5,000 | New | +$16.6K |
| D | 2022-02-16 | 2022-02-15 | BCRX | BIOCRYST PHARMACEUTICALS INC | ABERCROMBIE GEORGE B | Dir | S - Sale+OE | $18.50 | -5,000 | 0 | -100% | -$92.5K |
| D | 2021-11-17 | 2021-11-15 | BCRX | BIOCRYST PHARMACEUTICALS INC | ABERCROMBIE GEORGE B | Dir | S - Sale+OE | $12.27 | -5,000 | 0 | -100% | -$61.4K |
| D | 2021-11-17 | 2021-11-15 | BCRX | BIOCRYST PHARMACEUTICALS INC | ABERCROMBIE GEORGE B | Dir | M - OptEx | $3.32 | +5,000 | 5,000 | New | +$16.6K |
| D | 2021-09-17 | 2021-09-15 | BCRX | BIOCRYST PHARMACEUTICALS INC | ABERCROMBIE GEORGE B | Dir | S - Sale+OE | $15.06 | -5,000 | 0 | -100% | -$75.3K |
| D | 2021-09-17 | 2021-09-15 | BCRX | BIOCRYST PHARMACEUTICALS INC | ABERCROMBIE GEORGE B | Dir | M - OptEx | $2.63 | +5,000 | 5,000 | New | +$13.2K |
| D | 2021-09-14 | 2021-09-10 | BCRX | BIOCRYST PHARMACEUTICALS INC | ABERCROMBIE GEORGE B | Dir | S - Sale+OE | $15.09 | -74.0K | 0 | -100% | -$1.12M |
| DM | 2021-09-14 | 2021-09-10 | BCRX | BIOCRYST PHARMACEUTICALS INC | ABERCROMBIE GEORGE B | Dir | M - OptEx | $2.86 | +71.0K | 74.0K | +2,367% | +$202.7K |
| D | 2021-07-19 | 2021-07-15 | BCRX | BIOCRYST PHARMACEUTICALS INC | ABERCROMBIE GEORGE B | Dir | S - Sale+OE | $15.69 | -5,000 | 3,000 | -62% | -$78.5K |
| D | 2021-07-19 | 2021-07-15 | BCRX | BIOCRYST PHARMACEUTICALS INC | ABERCROMBIE GEORGE B | Dir | M - OptEx | $2.63 | +5,000 | 8,000 | +167% | +$13.2K |
Purchase Sale Sale after option exercise All abbreviations